Breakthrough depression therapy enters final Long-Term testing phase
NCT ID NCT06605105
Summary
This study follows up on earlier trials to see how safe and effective the investigational treatment CYB003 is over the long term for people with major depressive disorder. It includes 468 participants who have already completed one of two previous CYB003 studies. The main goal is to monitor participants' depression symptoms and safety for an extended period, with the option for additional treatment doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adams Clinical
Watertown, Massachusetts, 02472, United States
-
Adams Clinical Boston
Boston, Massachusetts, 02116, United States
-
Atlanta Center For Medical Research
Atlanta, Georgia, 30331, United States
-
Cedar Clinical Research
Draper, Utah, 84020, United States
-
CenExel iResearch
Savannah, Georgia, 31405, United States
-
Cenexel iResearcvh Atlanta, LLC
Atlanta, Georgia, 30030, United States
-
Clinical Neuroscience Solutions, Inc
Orlando, Florida, 32801, United States
-
Combined Research Orlando
Phoenix, Arizona, 85022, United States
-
InSite Clinical Research, LLC
DeSoto, Texas, 75115, United States
-
K2 Medical Research
Lady Lake, Florida, 32159, United States
-
Mountain View Clinical Research
Denver, Colorado, 80209, United States
-
Neurobehavioral Clinical Research
Canton, Ohio, 44720, United States
-
Open Mind Collective / UCSF Medical Center - Mount Zion
San Francisco, California, 94114, United States
-
Psychiatric Medicine Associates, LLC
Skokie, Illinois, 60076, United States
-
Research Centers of America
Hollywood, Florida, 33024, United States
-
Segal Trials Center for Psychedelic Research
Lauderhill, Florida, 33319, United States
-
Starlight Clinical Research
Evergreen, Colorado, 80439, United States
-
Sunstone Medical, PC
Rockville, Maryland, 20850, United States
-
Uptown Research Institute
Chicago, Illinois, 60640, United States
Conditions
Explore the condition pages connected to this study.